Disclosures for "Rethinking Headache in Multiple Sclerosis as a Feature of Relapsing Disease Biology and Early Neuroinflammation"
-
The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS). Dr. Michaelson has received research support from Sanofi.
-
Ms. Balshi has nothing to disclose.
-
Miss Manning has nothing to disclose.
-
Mr. Dempsey has nothing to disclose.
-
Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Sloane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.